The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: A meta-analysis.

Authors

null

Michael Luke Marinovich

Screening and Test Evaluation Program (STEP), The University of Sydney, Australia

Michael Luke Marinovich , Lamiae Azizi , Petra Macaskill , Les Irwig , Monica Morrow , Lawrence J. Solin , Nehmat Houssami

Organizations

Screening and Test Evaluation Program (STEP), The University of Sydney, Australia, Memorial Sloan Kettering Cancer Center, New York, NY, Albert Einstein Medical Center, Philadelphia, PA

Research Funding

Other

Background: There is no consensus on what constitutes adequate negative margins in breast-conserving surgery (BCS) for ductal carcinoma in-situ(DCIS). We systematically review the evidence on surgical margins in BCS for DCIS. Methods: Study-level meta-analysis of studies reporting local recurrence (LR) relative to microscopic margin status and threshold distance for negative margins. LR proportion was modelled using random-effects logistic meta-regression (frequentist) that dichotomised data using one margin distance, and network meta-analysis (Bayesian) that allows for multiple margin distances per study, adjusting for follow-up time. Results: Based on 33 studies (LR in 865 of 7,883), theodds of LR were associated with margin status (logistic: odds ratio (OR) 0.53 for negative vs positive/close [P<0.001]; network: OR=0.45 for negative vs positive). In logistic meta-regression models, relative to >0 or 1mm, ORs for 2mm (0.51), 3 or 5mm (0.42) and 10mm (0.60) thresholds showed comparable significant reductions in the odds of LR. Odds of LR did not differ between 2mm, 3 or 5mm, and 10mm (all P>0.40). Predicted probabilities of LR at 10 years were 18.1% (>0 or 1mm), 10.1% (2mm), 8.5% (3 or 5mm), and 11.7% (10mm). In the network analysis, ORs relative to positive margins for 2mm (0.32), 3mm (0.30) and 10mm (0.32) showed similar reductions in the odds of LR that were greater than for >0 or 1mm (0.45). There was weak evidence of lower odds at 2mm compared to >0 or 1mm (Relative OR=0.72, 95% credible interval [CrI] 0.47-1.08), and no evidence of a difference between 2mm and 10mm (Relative OR=0.99, 95% CrI 0.61-1.64). Adjustment for covariates (age; median recruitment year; and proportions with radiotherapy, endocrine therapy, or high grade DCIS), and analyses based only on studies using whole-breast radiotherapy, did not change findings. Conclusions: Negative margins in BCS for DCIS reduce the odds of LR; however, minimum margins distances above 2mm are not significantly associated with further reduced odds of LR in women receiving radiation.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Local Therapy

Citation

J Clin Oncol 34, 2016 (suppl; abstr 1020)

DOI

10.1200/JCO.2016.34.15_suppl.1020

Abstract #

1020

Poster Bd #

125

Abstract Disclosures

Similar Abstracts